Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

More often than not, takeover speculation can give a lively boost -- at least in the short term -- to a company's stock. That ...

Pharmaceutical giant Johnson & Johnson has been heavily investing in North Carolina , spending billions on its Wilson factory ...

Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis ...

NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today ...

Now, it’s worth noting Stock Advisor’s total average return is 969 % — a market-crushing outperformance compared to 196% for ...

Amid the current debate over the devastating impact of recent aid cuts on global health programmes, the question of ...

Lakewood-Amedex Biotherapeutics filed to go public through a direct listing. The pharmaceutical company said it will sell 4.7 million units, according to a filing with the Securities and Exchange ...

As of Friday, January 09, Rigel Pharmaceuticals, Inc.’s RIGL share price has dipped by 5.01%, which has investors questioning ...

Thinking about age as a modifiable risk factor is reshaping how veterinarians approach care for aging dogs.

With Johnson & Johnson’s participation, 15 of 17 companies contacted by the administration over the summer have now signed on ...

Singapore-based biotechnology company Umami Bioworks has announced advancements to its artificial intelligence (AI) ...